Board of Directors 2017-08-30T10:27:01+00:00

About the Board

Executive Committee:


Phillip Grimm, Chairman, brings 25+ years of proven track record in managing both large scale organizations and emerging businesses. Serving as the Chief Financial Officer and then the General Manager of DOD Electronics, Mr. Grimm was instrumental in growing this high technology consumer electronics business from sub $10 million revenue to more than $50 million in a short three years.

After successfully serving in Corporate America at executive levels for almost 15 years with such companies as Motorola, Bomar Instrument, Harman International and Bull HN Information System, Mr. Grimm decided to venture into developing his own portfolio of business ventures and successfully completed acquisitions, business stabilization and growth, culminating in successful exits with high multiple returns over a 10 year period.

Some of his prior companies in this area are US Currency Protection Corporation, Global Pursuit Systems, GeoTrax, and Flight Link. Post his M&A business, Mr. Grimm served as the CEO for DxNA LLC, a company bringing leading edge technology to the Biomedical field in the area of rapid and portable disease-diagnostic solutions. Since 2011, Mr. Grimm has been devoting his time to his consulting services, mentoring emerging businesses and participating in early stage financial investments.

 


Bradley Bertoch

Bradley B. Bertoch, President & CEO, VentureCapital.org. He is a leader in equity backed business development and entrepreneurship. Under his direction, companies participating in WBI programs have raised over $5 billion in private and public equity and created or retained over 100,000 high tech jobs throughout the United States. Bertoch is a member of the SLC Angels, the Salt Lake Life Sciences Angels, the Park City Angels and the WBI Angels and was a venture partner with Hamilton Bio-Ventures Fund II. He is a graduate of Northwestern University’s Kellogg School of Management.

 

 

 


Lynn Butterfield has been with Coldwell Banker in Salt Lake City/Park City, Utah for more than fourteen years, where he is a Managing Broker. Mr. Butterfield was formerly Manager of West Coast Business Development for UVEST Investment Services, a Charlotte, North Carolina Investment Bank.  He is a nationally recognized expert in equity capital and investing services. He has been a resource for, and has been quoted by, organizations such as Newsweek and ABC News. He has worked with emerging and expanding companies from Silicon Valley to Wall Street, and China to the Middle East for the past twenty-five years where he developed his global expertise in business development and expansion. He developed his equity-backed business experience by working with companies and venture capitalists in “hands-on” business development. His investment banking experience was developed in New York City as a Senior Vice President with Wall Street-based investment bank – BlueStone Capital Partners. Previous to Mr. Butterfield’s Wall Street experience, he worked as a financial planner for IDS Financial Services, a division of American Express, where he was ranked fourth in the number of plans sold in the Rocky Mountain Region.  He was listed in “Outstanding Young Men of America” in 1987 and is the former Chairman of the Credit Committee at America First Credit Union, one of America’s largest credit unions. Mr. Butterfield also earned the Edward A. Filene Award, the Friedrich W. Raiffeisen Award and the Roy F. Bergengren Award as a volunteer in the Credit Union Movement where he assisted individuals in building a solid financial foundation. He is a Trustee for and former COO of VentureCapital.org, a nationally recognized nonprofit organization that helps entrepreneurs to Start Companies, Find Money and Change the World. Mr. Butterfield is a member of the Board of Trustees for Special Olympics Utah where is serves as a member of the Governance Committee. He is a member of the floor staff for University of Utah Gymnastics, the most winning gymnastics program in NCAA History.  He is also a graduate of the University of Utah where he received both B.S. and M.S. degrees.

 


Jerry Vance

Jerry Vance is a managing member of Preferred CFO Solutions, a full service consulting firm that provides its clients with outsourced finance and accounting solutions. From high-level CFO consulting to controller and basic accounting functions, Preferred CFO’s timely results give management teams of all sized companies the information and support that they need to make critical decisions.

 

 

 


Matt Warnock

Matt Warnock, a recovering attorney, practiced law in California’s Silicon Valley area before relocating to Utah in 1998. Matt came to Utah to work on multiple M&A transactions for a private venture company. He joined RidgeCrest Herbals as COO in 2001, and added the title of VP Marketing in 2003. He was appointed President in 2005, and became a co-owner in 2007. Today he leads a talented team that has continued to innovate and break new ground in natural remedies. Matt has been an Entrepreneur in Residence at the Wayne Brown Institute and a member of WBI’s Cooperate Venturing Network® (mentoring network) for 15 years. He is a graduate of BYU and the J. Rueben Clark BYU School of Law.

 

 

Board of Trustees:


Bob GottdenerChris Anderson, Durham, Jones & Pinegar, is a Shareholder in the Firm’s Salt Lake City and Lehi offices. His practice focuses on M&A, Business and Finance, Private Equity, Securities, International, Life Sciences, and other technologies. Mr. Anderson has worked for many years in the venture capital arena, representing both investors and their portfolio companies. He enjoys representing high-growth companies throughout their life-cycle, with respect to both financing transactions and the myriad business transactions they deal with.

 


Ron Bell

Ron Bell, Vice President, Communications Products, Micro Linear. Bell spent 25 years at Unysis and was its chief technology officer and a Unysis Fellow. From there, he joined LSI Logic as its vice president of Advanced Architecture. Most recently, he was CEO of Equator Technologies. Bell was instrumental in the commercialization of the microprocessor.

 

 

 


Bob Gottdener

Bob Gottdener, Senior Vice President, Merrill Lynch. Gottdener has over 40 years of investment experience. He graduated from the University of Illinois and earned a certificate from the Securities Industry Association at the Wharton Business School. Gottdener specializes in working with high growth companies that have high potential to go public. While at Alex Brown he brought to fruition 16 IPOs. He is a member of VentureCapital.org’s Cooperative Venturing® Network and acts as a mentor for early stage companies.

 

 


Jerry Henley

Jerry Henley is currently the Managing Partner of Rubicon Capital Consultants (RCC). RCC focuses on bridging the gap between successful companies and the “right” value added financial partner. RCC geographical expertise is in the western United States with an emphasis in the Intermountain West. Although Mr Henley has owned many small businesses he cut his teeth with Sorenson Capital, which has over a billion dollars under management. He joined Sorenson Capital Partners (SCP) as the VP of Marketing in May 2011 and, through his well-established networks, focused on the firm’s sourcing and marketing efforts. In late 2013 he took a sabbatical from full time with SCP to become the Managing director with a large software development company where he and his team turned the company from declining year over year sales to a 50% growth model. During that time and to this date he still consults with SCP in the area of M & A. Prior to joining Sorenson Capital, he was Associate Director with the Office of the President at Brigham Young University where he worked very closely with the national business community in major fundraising projects. Mr. Henley’s background includes 17 years with Amgen Biotech and 4 years with Pfizer. He started carrying a bag and eventually was promoted to numerous positions in Corporate Accounts over Integrated Health Systems and also Government contracts.

Michael Keene is currently both the Director of Graduate Business Programs and the Director of the MBA in Technology Management Program in the Gore School of Business at Westminster College. Dr. Keene holds a B.A. in Biochemistry from Princeton University, a MBA and a Ph.D. in Biochemistry and Molecular Biology from Harvard University. Over the last 25 years he has conducted and managed programs in fields ranging from environmental remediation to fuel cells, and cystic fibrosis to fruit fly genetics. Although widely published during his research career, he soon left academia to become a member of the start-up team for Integrated DNA Technologies, Inc., and has since been an executive, founder or board member for a number of technology-based firms. Prior to joining Westminster, he served as both the State Science Advisor and Director of the Utah Centers of Excellence Program under Governors Leavitt and Walker. A co-founder of the Utah Life Sciences Association, he also now sits on the Advisory Council for the Centers of Excellence Program and the board of the Utah Technology Council, and remains active as a company mentor for the Wayne Brown Institute, an external reviewer for the University of Utah’s Technology Commercialization Office, and in numerous other roles within the local community.

 


Elliot Parks

Elliot Parks is managing director of Hamilton BioVentures, a life science venture firm in San Diego. He is widely known in the Biotechnology industry and brings his broad experiences as a life science investor, an entrepreneur, a pharmaceutical executive, and a distinguished researcher. He has overseen the development of several biomedical products from inception through development and from clinical trials to approval and market entry. Prior to joining Hamilton, Dr. Parks was responsible for life science investments at Ventana Capital Management for five years. Before entering institutional venture capital, he was President and CEO of Myelos Neurosciences and Director of the Johnson & Johnson Biotechnology Center, both in San Diego. Dr. Parks was also a member of the Scripps Research Institute, in La Jolla, for over a decade and the Director of Operations there before joining J&J.

 


David Rudd

David Rudd is a partner in the Business and Finance Department at Ballard Spahr LLP, partner-in-charge of the International Group, and a member of the Life Sciences/Technology, Energy and Project Finance, Mergers and Acquisitions/Private Equity, P3/Infrastructure, and Securities Groups. Mr. Rudd practices exclusively in the area of complex domestic and international business transactions in a wide variety of legal fields and industrial sectors.